ReviewHaematologica2019

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.

Lucia Prieto-Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.